Skip to main content
. 2011 Dec 28;5(1):49–60. doi: 10.3390/ph5010049

Table 1.

Representative RNA aptamers assayed for their ex vivo inhibition of HCV replication.

Group Aptamer Sequence *
I
(5'-RGUGRR-3'
P8-27 graphic file with name pharmaceuticals-05-00049-i001.jpg
P9-39 graphic file with name pharmaceuticals-05-00049-i002.jpg
I y IV P6-45 graphic file with name pharmaceuticals-05-00049-i003.jpg
II
5'-GGYUGUG-3'
P7-54 graphic file with name pharmaceuticals-05-00049-i004.jpg
P9-34 graphic file with name pharmaceuticals-05-00049-i005.jpg
II y IV P6-91 graphic file with name pharmaceuticals-05-00049-i006.jpg
III
5'-YGGGYR-3'
P7-14 graphic file with name pharmaceuticals-05-00049-i007.jpg
P8-65 graphic file with name pharmaceuticals-05-00049-i008.jpg
P8-68 graphic file with name pharmaceuticals-05-00049-i009.jpg
P8-71 graphic file with name pharmaceuticals-05-00049-i010.jpg
III y IV P6-99 graphic file with name pharmaceuticals-05-00049-i011.jpg
P9-15 graphic file with name pharmaceuticals-05-00049-i012.jpg
IV
5'-YGUGUG-3'
P6-2 graphic file with name pharmaceuticals-05-00049-i013.jpg
P6-20 graphic file with name pharmaceuticals-05-00049-i014.jpg
P9-37 graphic file with name pharmaceuticals-05-00049-i015.jpg
V
5'-UGGGGR-3'
P9-8 graphic file with name pharmaceuticals-05-00049-i016.jpg

* Sequence of the variable region is shown. Common sequence is highlighted in grey for group I aptamers, in blue for group II aptamers, boxed for group III aptamers, highlighted in green for group IV aptamers and in red for group V aptamers.